MyD88-mediated chimaeric antigen receptor macrophages suppress brain metastasis using target-specific phagocytosis
- 2 March 2026
- journal article
- research article
- Published by Springer Nature in Nature Biomedical Engineering
- p. 1-19
Abstract
Metastatic brain disease occurs in up to 30% of patients with lung, melanoma and breast cancers, and the median survival time remains less than a year. Treating these patients is a challenge because surgical approaches are limited and most chemotherapeutic drugs and immunotherapies are ineffective at crossing the blood–brain barrier (BBB). Given the unique abilities of macrophages to cross the BBB and exert their phagocytic function on tumour cells, we genetically engineer macrophages that express a chimaeric antigen receptor (CAR) targeting mesothelin (MSLN). To specifically target metastatic brain tumours, we fused the cells with the immune signalling molecule MyD88. This chimaeric antigen receptor macrophage (CARMA) penetrates the BBB and decreases brain metastasis growth in a humanized mouse model. MSLN–CARMA shows antigen-specific phagocytosis activity against tumour cells and exhibits a bystander effect by releasing TNF to act on surrounding tumour cells lacking the tumour antigen. These features of CARMA represent advantages over other immune therapies and CARMA may serve as a promising therapeutic tool for the treatment of brain metastasis.Keywords
Funding Information
- Foundation for the National Institutes of Health (RO1CA173499)
- Foundation for the National Institutes of Health (R01CA185650)
- Foundation for the National Institutes of Health (R01CA205067)
- Foundation for the National Institutes of Health (K99CA276895)
- U.S. Department of War (W81XWH2110075)
This publication has 92 references indexed in Scilit:
- Phagocytosis of Necrotic Cells by Macrophages Is Phosphatidylserine Dependent and Does Not Induce Inflammatory Cytokine ProductionMolecular Biology of the Cell, 2004
- Differential Role of MyD88 in Macrophage-Mediated Responses to Opportunistic Fungal PathogensInfection and Immunity, 2003
- The Organizing Principle in the Formation of the T Cell Receptor-CD3 ComplexCell, 2002
- Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: Identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE)2001
- Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector moleculeNature Immunology, 2000
- TNF-α Signals Apoptosis through a Bid-Dependent Conformational Change in Bax that Is Inhibited by E1B 19KMolecular Cell, 2000
- Mesothelin Is Not Required for Normal Mouse Development or ReproductionMolecular and Cellular Biology, 2000
- Dynamic Interactions of Macrophages with T Cells during Antigen PresentationJournal of Experimental Medicine, 1999
- Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated FunctionImmunity, 1998
- Treatment of Advanced Cancer by Extracorporeal Perfusion and Continuous Intra-Arterial InfusionProceedings of the Royal Society of Medicine, 1962